Loading candles…
Lincoln Pharmaceuticals Ltd, incorporated in 1979, operates in the pharmaceutical industry primarily in India with exports to over 60 countries across Africa, Latin America, Southeast Asia, and Europe. The company is engaged in manufacturing and marketing pharmaceutical therapeutic molecules, focusing on branded generics. Its product range includes pharmaceutical products such as tablets, capsules, injectables, and syrups, serving more than 15 therapeutic areas. Lincoln Pharmaceuticals conducts its operations through two manufacturing facilities in Gujarat, one of which is a dedicated Cephalosporin plant. The company maintains a net debt-free balance sheet. It operates without listed subsidiaries or ventures and is not listed on any stock exchange.
This page is a live market overview for LINCOLN PHARMA LTD (LINCOLN) on the NSE. As a listed security, LINCOLN PHARMA LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for LINCOLN before placing trades on tick2trade.
As of the latest feed, LINCOLN last traded at ₹600.15 on NSE, down ₹6.05 (1.00%) from the previous close of ₹606.2. Today's session range is ₹591.5 – ₹608.25, against a 52-week band of ₹440 – ₹770. Traded volume today stands at 22.32K shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for LINCOLN in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether LINCOLN is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for LINCOLN PHARMA LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in LINCOLN. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated LINCOLN option chain page linked from this overview.
| Unaudited Results - FY25 | Intimation of Board Meeting to consider and approve the unaudited financial results for the period ended Jun 30, 2025. | 7 Aug 2025 |
| Audited Results - Q4 & FY25 | To consider and approve the Audited (Standalone & Consolidated) financial results for the Quarter and Year ended March 31, 2025 and recommendation of dividen… | 22 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.